Masimo Total Depreciation and Amortization - Cash Flow 2010-2024 | MASI
Masimo annual/quarterly total depreciation and amortization - cash flow history and growth rate from 2010 to 2024. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
- Masimo total depreciation and amortization - cash flow for the quarter ending December 31, 2024 was $0.105B, a 4.69% increase year-over-year.
- Masimo total depreciation and amortization - cash flow for the twelve months ending December 31, 2024 was $0.252B, a 1.48% decline year-over-year.
- Masimo annual total depreciation and amortization - cash flow for 2024 was $0.105B, a 4.69% increase from 2023.
- Masimo annual total depreciation and amortization - cash flow for 2023 was $0.1B, a 27.13% decline from 2022.
- Masimo annual total depreciation and amortization - cash flow for 2022 was $0.138B, a 286.24% increase from 2021.
| Masimo Annual Total Depreciation and Amortization - Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $105 |
| 2023 | $100 |
| 2022 | $138 |
| 2021 | $36 |
| 2020 | $29 |
| 2019 | $23 |
| 2018 | $21 |
| 2017 | $20 |
| 2016 | $17 |
| 2015 | $16 |
| 2014 | $13 |
| 2013 | $11 |
| 2012 | $9 |
| 2011 | $7 |
| 2010 | $7 |
| 2009 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $8.993B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||